Precision for Medicine Acquires ACT Oncology         

ACT Oncology's Management Team is comprised of clinical research veterans with a shared passion for oncology development and a commitment to providing outstanding support on behalf of our Sponsors' development programs.  Averaging more than 20 years of industry experience, our Management Team members have backgrounds including key leadership roles at biotechnology, pharmaceutical and CRO companies.  Our senior operational personnel have all led pivotal oncology clinical development programs and are able to incorporate this expertise into optimizing the strategy and implementation of each new partnership.  

Click on the names below to view full biographies for each member of our Management Team.

Julia A. Amo, MBA, PMP

Chief Operating Officer

Gene Vodovoz

Chief Financial Officer

Jeffrey D. Seroskie, M.S.

Corporate Vice President

Heidi Vosseler, R.N., CCRN

Executive Director, Clinical Operations

Robert F. Ott, MBA

Executive Director, Business Operations

Joseph A. Parks M.S., RQAP-GCP

Vice President, Quality and Compliance

Chris Ellis

Senior Director, Business Development
chris.ellis@actoncology.com

Romy A. Kane, MBA

Senior Director of Operational Finance

Patricia Terek

Senior Director, Business Development
pat.terek@actoncology.com

We're changing our name and website to reflect our exciting new capabilities since joining Precision for Medicine. Please visit us at precisionforoncology.com to see how we’re delivering the next generation of CRO services for oncology innovators.